DYN Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.06% compare to its pairs and should correct upwards.

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States...

Stats
Šios dienos apimtis	2.94M
Vidutinė apimtis	1.16M
Rinkos kapitalizacija	3.45B
EPS	$-0.810 ( Q1 \| 2024-05-02 )
Kita pelno data	( $-0.720 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.87 (Sector) 49.64 (Industry) 46.06
ATR14	$0.0670 (0.19%)

ADCT 12.46%

AMAM 0.07%

ANRO 0.56%

ANTX -3.59%

BHVN -1.08%

BWV -6.97%

DNA 8.12%

DNA-WT -0.35%

DYN -0.37%

GLS 0.00%

KDMN 0.00%

MYOV -0.04%

NUVB -3.95%

NUVB-WT -0.18%

NVO -1.21%

PRME -3.56%

RCUS 0.40%

SQZ 61.11%

TOVX -2.80%

ZYME 1.19%

Insider Trading

Date	Person	Action	Amount	type
2024-06-21	High Susanna Gatti	Buy	29 787	Common Stock
2024-06-24	High Susanna Gatti	Buy	10 163	Common Stock
2024-06-21	High Susanna Gatti	Sell	29 787	Common Stock
2024-06-24	High Susanna Gatti	Sell	10 163	Common Stock
2024-06-21	High Susanna Gatti	Sell	29 787	Stock option (right to buy)

INSIDER POWER
-3.69
Last 100 transactions
Buy: 1 763 447 \| Sell: 1 894 077

Koreliacija (AI algo v.1.1b): Undervalued: 0.06% $35.31 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: 0.70 (moderate)

Trumpas: -0.36 (neutral)

Signal:(70.691) Neutral

Dynegy Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
ADX	0.935
ELME	0.931
BRO	0.93
TDVG	0.924
QLV	0.924
OEF	0.924
XLG	0.923
NACP	0.922
MGC	0.921
IHDG	0.921

10 Labiausiai neigiamai susiję koreliacijos
BYON	-0.944
QBTS	-0.915
SPXU	-0.912
SPXS	-0.911
SSG	-0.908
SDS	-0.907
VLD	-0.902
FNGD	-0.9
EHAB	-0.9
GAM-PB	-0.9

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Dynegy Inc. Koreliacija - Valiuta/Žaliavos

-0.47
( neutral )

-0.61
( weak negative )

0.00
( neutral )

-0.10
( neutral )

0.00
( neutral )

0.42
( neutral )

Dynegy Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$0
Bruto pelnas:	$-2.46M (0.00 %)
EPS:	$-3.95

FY	2023
Pajamos:	$0
Bruto pelnas:	$-2.46M (0.00 %)
EPS:	$-3.95

FY	2022
Pajamos:	$0
Bruto pelnas:	$-3.35M (0.00 %)
EPS:	$-3.18

FY	2021
Pajamos:	$0.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-2.93

Financial Reports:

No articles found.

Dynegy Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Dynegy Inc.

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..